Literature DB >> 29052116

Patients' knowledge on oral anticoagulant treatment in Hungary.

Reka Viola1, Helga Fekete2, Ildiko Csoka2.   

Abstract

Background A key element for an effective and safe oral anticoagulant treatment (OAT) is to have the relevant information delivered to patients in an easy-to-understand way and thus have them apply this knowledge in their own therapy. Objective To assess knowledge about OAT, reveal knowledge gaps and identify at-risk patients in terms of limited knowledge about their anticoagulant therapy. Setting Community pharmacies in Hungary. Methods This descriptive cross-sectional study used a structured, validated, self-developed questionnaire to assess patients' knowledge about OAT. Scores were calculated on each domain and the association between knowledge and patients' or treatment characteristics were analysed. Responses in all domains were assessed to identify at-risk patients and knowledge gaps. Main outcome measures Knowledge and knowledge gaps on OAT, and risk factors for limited knowledge. Results The questionnaire developed based on four validated questionnaires passed the field test and had a good internal consistency (Cronbach α = 0.795). Our full patient population (N = 427) had a mean percentage score of 59.39 (29.7% good, 41.2% average, 29.0% poor knowledge on OAT). Poor knowledge level was found to significantly correlate with advanced age (> 75 years), lower education, diagnosis of atrial fibrillation, and unawareness of the indication of OAT. The lowest frequency of correct answers regarded the questions on drug interactions (10.2%) and diet (11.4%). Pharmacists were infrequently indicated as the healthcare professionals to share information with regarding OAT (12.7%). Conclusion Findings of our study offer a valuable insight into the required directions of developing new strategies for patient education to improve knowledge on the treatment with oral anticoagulants.

Entities:  

Keywords:  Hungary; Oral anticoagulant therapy; Patient education; Pharmaceutical care; Therapy-related knowledge

Mesh:

Substances:

Year:  2017        PMID: 29052116     DOI: 10.1007/s11096-017-0544-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  25 in total

1.  Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis.

Authors:  Christian Borg Xuereb; Rachel L Shaw; Deirdre A Lane
Journal:  Patient Educ Couns       Date:  2012-06-26

2.  New educational approach for patients on warfarin improves knowledge and therapy control.

Authors:  Alenka Mavri; Nina Ostasevski Fernandez; Anja Kramaric; Katarina Kosmelj
Journal:  Wien Klin Wochenschr       Date:  2015-04-01       Impact factor: 1.704

Review 3.  Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.

Authors:  Antonio Hernández Madrid; Tatjana S Potpara; Nikolaos Dagres; Jian Chen; Torben B Larsen; Heidi Estner; Derick Todd; Maria G Bongiorni; Elena Sciaraffia; Alessandro Proclemer; Saida Cheggour; Walid Amara; Carina Blomstrom-Lundqvist
Journal:  Europace       Date:  2016-02-21       Impact factor: 5.214

4.  Factors affecting warfarin-related knowledge and INR control of patients attending physician- and pharmacist-managed anticoagulation clinics.

Authors:  Syed S Hasan; R Shamala; Imran A Syed; N Basariah; David W K Chong; Teh K Mei; Ong H Chin
Journal:  J Pharm Pract       Date:  2011-08-15

5.  The development and performance validation of a tool to assess patient anticoagulation knowledge.

Authors:  Amber L Briggs; Terrence R Jackson; Susan Bruce; Nancy L Shapiro
Journal:  Res Social Adm Pharm       Date:  2005-03

6.  Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.

Authors:  B Bajorek; P J Magin; S Hilmer; I Krass
Journal:  J Clin Pharm Ther       Date:  2016-08       Impact factor: 2.512

Review 7.  Venous thromboembolism: epidemiology and magnitude of the problem.

Authors:  Samuel Z Goldhaber
Journal:  Best Pract Res Clin Haematol       Date:  2012-08-09       Impact factor: 3.020

8.  Relationship between patients' warfarin knowledge and anticoagulation control.

Authors:  Elaine Othilia Y L Tang; Cemen S M Lai; Kenneth K C Lee; Raymond S M Wong; Gregory Cheng; Thomas Y K Chan
Journal:  Ann Pharmacother       Date:  2003-01       Impact factor: 3.154

9.  Evaluation of patients' knowledge on warfarin in outpatient pharmacy of a tertiary care cardiac center.

Authors:  Sweta Shrestha; Binaya Sapkota; Anjana Kumpakha; Upasana Acharya; Rashmi Sharma
Journal:  BMC Res Notes       Date:  2015-09-10

10.  Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.

Authors:  Xiaoxi Yao; Neena S Abraham; G Caleb Alexander; William Crown; Victor M Montori; Lindsey R Sangaralingham; Bernard J Gersh; Nilay D Shah; Peter A Noseworthy
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.